NYSE:VEEV - US9224751084 - Common Stock
Taking everything into account, VEEV scores 7 out of 10 in our fundamental rating. VEEV was compared to 35 industry peers in the Health Care Technology industry. Both the health and profitability get an excellent rating, making VEEV a very profitable company, without any liquidiy or solvency issues. VEEV is not overvalued while it is showing excellent growth. This is an interesting combination. With these ratings, VEEV could be worth investigating further for growth and quality investing!.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.12% | ||
ROE | 12.2% | ||
ROIC | 10.28% |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | 27.96% | ||
PM (TTM) | 27.29% | ||
GM | 75.59% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Altman-Z | 21.65 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 5.57 | ||
Quick Ratio | 5.57 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 36.24 | ||
Fwd PE | 31.74 |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 33.22 | ||
EV/EBITDA | 38.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
269.98
+0.78 (+0.29%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | 36.24 | ||
Fwd PE | 31.74 | ||
P/S | 14.86 | ||
P/FCF | 33.22 | ||
P/OCF | 32.7 | ||
P/B | 6.65 | ||
P/tB | 7.16 | ||
EV/EBITDA | 38.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | 10.12% | ||
ROE | 12.2% | ||
ROCE | 12.31% | ||
ROIC | 10.28% | ||
ROICexc | 203.55% | ||
ROICexgc | N/A | ||
OM | 27.96% | ||
PM (TTM) | 27.29% | ||
GM | 75.59% | ||
FCFM | 44.74% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0 | ||
Debt/FCF | 0 | ||
Debt/EBITDA | 0 | ||
Cap/Depr | 53.26% | ||
Cap/Sales | 0.71% | ||
Interest Coverage | 250 | ||
Cash Conversion | 155.11% | ||
Profit Quality | 163.97% | ||
Current Ratio | 5.57 | ||
Quick Ratio | 5.57 | ||
Altman-Z | 21.65 |